Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Alafenamide

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
GenvoyaAU CA CZ ES EU GB LV MX TW US
  • tablet ×8 Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 10 mg
  • tablet ×4 Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Alafenamide
  • tablet ×3 Cobicistat 90 mg + Elvitegravir 90 mg + Emtricitabine 120 mg + Tenofovir Alafenamide 6 mg
  • tablet ×2 Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir Alafenamide

Other 2 compositions

Gilead Sciences Ireland UC, Carrigtohill
Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tabletsES GB150 mg / 200 mg / 10 mg / 90 mg / 120 mg / 6 mgGilead Sciences Ireland Unlimited Company
elvitegravir + cobicistat + emtricitabina + tenofovir alafenamidaES150 mg / 200 mg / 10 mgGilead Sciences Ireland Unlimited Company
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamideUS150 mg / 200 mg / 10 mgGilead Sciences, Inc.
tenofovir alafenamide + emtricitabine + elvitegravir + cobicistatAU10 mg / 200 mg / 150 mgGilead Sciences Pty Limited
elvitegravir + cobicistat + tenofovir alafenamide fumarate + emtricitabine + tenofovir alafenamideAU——
捷扶康 膜衣錠TW
  • tablet Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Alafenamide
香港商吉立亞醫藥有限公司台灣分公司
GENVOYA elvitegravir (150mg), cobicistat (150mg), emtricitabine (200mg) and tenofovir alafenamide (as fumarate) (10mg) fixed dose combination tabletsAU
  • tablet Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 11.2 mg
Gilead Sciences Pty Ltd

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.